ClinicalTrials.govpublic full text
Efficacy and Safety of Pazopanib Monotherapy After First Line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
ovarian cancer, fallopian tube cancer, pazopanib, anti-angiogenesis, primary peritoneal cancer, tyrosine kinase inhibitors, gynecologic cancer, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 847869
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.